{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T14:17:09Z","timestamp":1784557029644,"version":"3.55.0"},"reference-count":26,"publisher":"Bioscientifica","content-domain":{"domain":["edm.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2014,2,1]]},"abstract":"<jats:title>Summary<\/jats:title>\n                  <jats:p>A 33-year-old male was diagnosed with a metastatic neuroendocrine carcinoma of uncertain primary. He defaulted from follow-up without therapy and some months later developed episodic severe hypoglycaemia, which was found to be associated with inappropriately elevated insulin and C-peptide levels. It was considered likely that the neuroendocrine tumour was the source of the insulin secretion. Diazoxide and somatostatin analogue were used to control hypoglycaemia. Much later in the course of the disease, he developed metabolic derangement, increased skin pigmentation and psychological disturbance, without frankly Cushingoid physical findings. Investigations revealed highly elevated cortisol levels (the levels having previously been normal) with markedly raised ACTH levels, consistent with the co-secretion of ACTH and insulin by the tumour. Treatment with metyrapone improved his psychological state and electrolyte imbalance. Unfortunately, despite several cycles of first-, second- and third-line chemotherapy from the start of the first hormonal presentation onwards, imaging revealed widespread progressive metastatic disease and the patient eventually passed away. This case highlights the importance of keeping in mind the biochemical heterogeneity of endocrine tumours during their treatment.<\/jats:p>\n                  <jats:sec>\n                    <jats:title>Learning points<\/jats:title>\n                    <jats:p>\n                      <jats:list list-type=\"bullet\">\n                        <jats:list-item>\n                          <jats:p>The clinical presentation of insulin-secreting tumours includes symptoms of neuroglycopaenia and sympathetic overstimulation.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>Tumour-associated hypoglycaemia can be due to pancreatic insulinomas, and although ectopic hormone production occurs in a number of tumours, ectopic secretion of insulin is rare.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>A possible switch in the type of hormone produced can occur during the growth and progression of neuroendocrine tumours and, when treating neuroendocrine tumours, it is important to keep in mind their biochemical heterogeneity.<\/jats:p>\n                        <\/jats:list-item>\n                      <\/jats:list>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1530\/edm-13-0082","type":"journal-article","created":{"date-parts":[[2014,2,20]],"date-time":"2014-02-20T08:23:20Z","timestamp":1392884600000},"update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-2","source":"Crossref","is-referenced-by-count":0,"title":["A case of insulin and ACTH co-secretion by a neuroendocrine tumour"],"prefix":"10.1530","volume":"2014","author":[{"given":"S","family":"Solomou","sequence":"first","affiliation":[{"name":"1Department of Endocrinology, Barts and the London School of Medicine, QMUL, W SmithfieldEC1A 7BE, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Khan","sequence":"additional","affiliation":[{"name":"1Department of Endocrinology, Barts and the London School of Medicine, QMUL, W SmithfieldEC1A 7BE, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Propper","sequence":"additional","affiliation":[{"name":"2Department of Oncology, Barts and the London School of Medicine, QMUL, W SmithfieldEC1A 7BE, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Berney","sequence":"additional","affiliation":[{"name":"3Department of Histopathology, Barts and the London School of Medicine, QMUL, W SmithfieldEC1A 7BE, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Druce","sequence":"additional","affiliation":[{"name":"1Department of Endocrinology, Barts and the London School of Medicine, QMUL, W SmithfieldEC1A 7BE, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","reference":[{"key":"ref151","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s11154-010-9139-z","article-title":"The ectopic ACTH syndrome","volume":"11","year":"2010","journal-title":"Reviews in Endocrine & Metabolic Disorders"},{"key":"ref161","doi-asserted-by":"crossref","first-page":"740","DOI":"10.3109\/0284186X.2010.492791","article-title":"Nordic guidelines for diagnosis and treatment of gastroenteropancreatic neuroendocrine tumours","volume":"49","year":"2010","journal-title":"Acta Oncologica"},{"key":"ref241","doi-asserted-by":"crossref","first-page":"600","DOI":"10.2337\/diab.24.6.600","article-title":"Amelioration of hypoglycemia in a patient with malignant insulinoma during the development of the ectopic acth syndrome","volume":"24","year":"1975","journal-title":"Diabetes"},{"key":"ref111","doi-asserted-by":"crossref","first-page":"600","DOI":"10.2337\/diab.24.6.600","article-title":"Amelioration of hypoglycemia in a patient with malignant insulinoma during the development of the ectopic acth syndrome","volume":"24","year":"1975","journal-title":"Diabetes"},{"key":"ref221","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1002\/1097-0142(19880315)61:6<1232::AID-CNCR2820610629>3.0.CO;2-4","article-title":"Multiple endocrine neoplasia type 1 with Cushing's disease, primary hyperparathyroidism, and insulin-glucagonoma","volume":"61","journal-title":"Cancer"},{"key":"ref251","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.4081\/es.2012.e7","article-title":"Neuroendocrine tumor presenting as metastatic carcinoid and later as insulinoma: a rare metamorphosis","volume":"2","year":"2012","journal-title":"Endocrinology Studies"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"740","DOI":"10.3109\/0284186X.2010.492791","article-title":"Nordic guidelines for diagnosis and treatment of gastroenteropancreatic neuroendocrine tumours","volume":"49","year":"2010","journal-title":"Acta Oncologica"},{"key":"ref171","doi-asserted-by":"crossref","first-page":"704","DOI":"10.2967\/jnumed.109.069765","article-title":"Functional imaging of neuroendocrine tumors: a head-to-head comparison of somatostatin receptor scintigraphy, 123I-MIBG scintigraphy, and 18F-FDG PET","volume":"51","year":"2010","journal-title":"Journal of Nuclear Medicine"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1210\/jcem.86.5.7461","article-title":"Carcinoid syndrome, acromegaly, and hypoglycemia due to an insulin-secreting neuroendocrine tumor of the liver","volume":"86","year":"2001","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s11154-010-9139-z","article-title":"The ectopic ACTH syndrome","volume":"11","year":"2010","journal-title":"Reviews in Endocrine & Metabolic Disorders"},{"key":"ref01","doi-asserted-by":"crossref","first-page":"829","DOI":"10.3748\/wjg.v19.i6.829","article-title":"Diagnosis and management of insulinoma","volume":"19","year":"2013","journal-title":"World Journal of Gastroenterology"},{"key":"ref71","first-page":"4617","article-title":"Clinical effect of temozolamide based chemotherapy in poorly differentiated endocrine carcinoma after progression on first line chemotherapy","volume":"11","year":"2011","journal-title":"Cancer"},{"key":"ref81","doi-asserted-by":"publisher","first-page":"22001","DOI":"10.1093\/annonc\/12.suppl_2.S83","article-title":"clinical heterogeneity of","volume":"12","author":"AngeliA","year":"1988","journal-title":"Annals Oncology"},{"key":"ref181","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1159\/000335597","article-title":"ENETS consensus guidelines for the management of patients with liver and other distance metastases from neuroendocrine neoplasms of foregut, midgut, hindgut and unknown primary","volume":"95","year":"2012","journal-title":"Neuroendocrinology"},{"key":"ref121","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.4081\/es.2012.e7","article-title":"Neuroendocrine tumor presenting as metastatic carcinoid and later as insulinoma: a rare metamorphosis","volume":"2","year":"2012","journal-title":"Endocrinology Studies"},{"key":"ref131","doi-asserted-by":"crossref","first-page":"829","DOI":"10.3748\/wjg.v19.i6.829","article-title":"Diagnosis and management of insulinoma","volume":"19","year":"2013","journal-title":"World Journal of Gastroenterology"},{"key":"ref141","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1210\/jcem.86.5.7461","article-title":"Carcinoid syndrome, acromegaly, and hypoglycemia due to an insulin-secreting neuroendocrine tumor of the liver","volume":"86","year":"2001","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref211","doi-asserted-by":"publisher","first-page":"22001","DOI":"10.1093\/annonc\/12.suppl_2.S83","article-title":"clinical heterogeneity of","volume":"12","author":"AngeliA","year":"1988","journal-title":"Annals Oncology"},{"key":"ref231","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/BF03347062","article-title":"Hyperinsulinemic hypoglycemia associated with ectopic Cushing's syndrome due to a pancreatic endocrine tumor in a type 2 diabetes mellitus patient: clinical implications of a rare association","volume":"34","year":"2011","journal-title":"Journal of Endocrinological Investigation"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1093\/annonc\/mds276","article-title":"Predictive and prognostic factors for treatment and survival in 305 patients with advanced gastrointestinal neuroendocrine carcinoma (WHO G3): the Nordic NEC study","volume":"24","year":"2013","journal-title":"Annals of Oncology"},{"key":"ref91","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1002\/1097-0142(19880315)61:6<1232::AID-CNCR2820610629>3.0.CO;2-4","article-title":"Multiple endocrine neoplasia type 1 with Cushing's disease, primary hyperparathyroidism, and insulin-glucagonoma","volume":"61","journal-title":"Cancer"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1159\/000335597","article-title":"ENETS consensus guidelines for the management of patients with liver and other distance metastases from neuroendocrine neoplasms of foregut, midgut, hindgut and unknown primary","volume":"95","year":"2012","journal-title":"Neuroendocrinology"},{"key":"ref101","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/BF03347062","article-title":"Hyperinsulinemic hypoglycemia associated with ectopic Cushing's syndrome due to a pancreatic endocrine tumor in a type 2 diabetes mellitus patient: clinical implications of a rare association","volume":"34","year":"2011","journal-title":"Journal of Endocrinological Investigation"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"704","DOI":"10.2967\/jnumed.109.069765","article-title":"Functional imaging of neuroendocrine tumors: a head-to-head comparison of somatostatin receptor scintigraphy, 123I-MIBG scintigraphy, and 18F-FDG PET","volume":"51","year":"2010","journal-title":"Journal of Nuclear Medicine"},{"key":"ref191","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1093\/annonc\/mds276","article-title":"Predictive and prognostic factors for treatment and survival in 305 patients with advanced gastrointestinal neuroendocrine carcinoma (WHO G3): the Nordic NEC study","volume":"24","year":"2013","journal-title":"Annals of Oncology"},{"key":"ref201","first-page":"4617","article-title":"Clinical effect of temozolamide based chemotherapy in poorly differentiated endocrine carcinoma after progression on first line chemotherapy","volume":"11","year":"2011","journal-title":"Cancer"}],"container-title":["Endocrinology, Diabetes &amp; Metabolism Case Reports"],"original-title":[],"link":[{"URL":"https:\/\/edm.bioscientifica.com\/view\/journals\/edm\/2014\/1\/EDM13-0082.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/edm.bioscientifica.com\/downloadpdf\/journals\/edm\/2014\/1\/EDM13-0082.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T13:45:53Z","timestamp":1784555153000},"score":1,"resource":{"primary":{"URL":"http:\/\/journals.bioscientifica.com\/edm\/article\/3117"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2,1]]},"references-count":26,"URL":"https:\/\/doi.org\/10.1530\/edm-13-0082","relation":{},"ISSN":["2052-0573","2052-0573"],"issn-type":[{"value":"2052-0573","type":"print"},{"value":"2052-0573","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,1]]}}}